Sign in

CIK 0001582313

  • Large accelerated filer

Xenon Pharmaceuticals Inc.

Sign in to watch
Ticker
XENE
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
British Columbia, Canada
Entity type
Operating
EIN
980661854
Phone
+1 604-484-3300
Business address
200 - 3650 GILMORE WAY, BURNABY, British Columbia, Canada
Open-market buys, last 90 days
$1,681,140
in 2 filings
Open-market sales, last 90 days
$425,829
in 1 filing, $426K under 10b5-1 plans

Net +$1,255,311. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2018-03-27 BVF PARTNERS L P/IL 10% owner Other acquisition · Series 1 Preferred Shares +1,338,000 1,338,000
2018-03-27 BVF PARTNERS L P/IL 10% owner Other acquisition · Series 1 Preferred Shares +861,000 861,000
2018-03-27 BVF PARTNERS L P/IL 10% owner Other acquisition · Series 1 Preferred Shares +238,000 238,000
2018-03-19 AYCARDI-FONSECA ERNESTO Chief Medical Officer Grant or award · Stock Option (Right to Buy) +50,000 50,000
2018-03-15 ROBIN SHERRINGTON EVP Bus. & Corp. Development Exercise or conversion +3,086 $3.77 $12K 7,820
2018-03-15 ROBIN SHERRINGTON EVP Bus. & Corp. Development Shares withheld for taxes −1,928 $4.63 $9K 5,892
2018-03-15 ROBIN SHERRINGTON EVP Bus. & Corp. Development Exercise or conversion · Stock Option (Right to Buy) −3,086 0
2018-03-14 HOLLER FRANK A Director Exercise or conversion +3,086 $3.77 $12K 118,955
2018-03-14 HOLLER FRANK A Director Exercise or conversion · Stock Option (Right to Buy) −3,086 0
2018-03-12 PIMSTONE SIMON N. CEO Exercise or conversion +10,288 $3.77 $39K 228,135
2018-03-12 PIMSTONE SIMON N. CEO Exercise or conversion · Stock Option (Right to Buy) −10,288 0
2018-03-12 COHEN CHARLES J. VP, Biology Grant or award · Stock Option (Right to Buy) +40,000 40,000
2018-03-12 EMPFIELD JAMES R. SVP, Drug Discovery Grant or award · Stock Option (Right to Buy) +45,000 45,000
2018-03-12 ROBIN SHERRINGTON EVP Bus. & Corp. Development Grant or award · Stock Option (Right to Buy) +55,000 55,000
2018-03-12 MORTIMER IAN PRESIDENT & CFO Grant or award · Stock Option (Right to Buy) +105,000 105,000
2018-03-12 PIMSTONE SIMON N. CEO Grant or award · Stock Option (Right to Buy) +140,000 140,000
2018-02-22 Hayden Michael R Director Gift −29,580 131,607
2018-02-22 Hayden Michael R Director Gift +21,180 97,066
2018-02-12 COHEN CHARLES J. VP, Biology Exercise or conversion +26,748 $3.71 $99K 26,748
2018-02-12 COHEN CHARLES J. VP, Biology Shares withheld for taxes −22,669 $3.50 $79K 4,079

Page 28 of 42 · 836 trades